The FDA record identifies Xuzhou Heabens Medical Technology Co., Ltd. as the applicant on 510(k) K262241 for an Electric Wheelchair (0080), product code ITI, regulation 21 CFR 890.3860, device class 2, under the Physical Medicine advisory committee. The filing was received on 2026-07-01 and decided on 2026-09-29 with decision code SESE, meaning substantially equivalent, through the traditional clearance route with a summary rather than a statement. The applicant is the legal party named in the filing; no parent, affiliate or brand owner is verified in the available records. [1][2][5]

The single documented FDA filing

K262241 is the only linked record in the current collection, and it is a 510(k) rather than a de novo or premarket approval submission. The decision count for the full collection is one SESE, and the explicitly smaller record sample of one entry carries the same single SESE decision; neither figure describes total company sales, total portfolio or safety performance. The record lists a third-party review flag of N and a clearance type of Traditional. [1][5]

Independent FDA-derived indexes reproduce the same core facts: applicant Xuzhou Heabens Medical Technology Co., Ltd., device Electric Wheelchair (0080), product code ITI, decision SESE dated 2026-09-29, and regulation 21 CFR 890.3860. One index places the record under Physical Medicine, Subpart D, and lists the classification name as Class II. [5][6]

Product identity and stated intended use

The cleared device is described in the filing as an Electric Wheelchair (0080) under the powered wheelchair classification. A comparison table in one FDA-derived index states the indication for use as a motor driven, indoor and outdoor transportation vehicle intended to provide mobility to a disabled or elderly person limited to a seated position. That wording is the index's rendering of the indication and should be checked against the official clearance before being relied on. [1][6]

The manufacturer's own website lists a range of electric wheelchair models under HEABENS identifiers, including HBS0010, HBS0011, HBS0014, HBS0020, HBS0026, HBS0030, HBS0141, HBS0141R, HBS0043, HBS0170, HBS0060, HBS0062, HBS0070, HBS0120, HBS0190, HBS0290, HBS0290HB and CF01, alongside an accessories category. The site does not map any of these model numbers to K262241, so which catalog model corresponds to the cleared device is unknown. [3]

Company statements and contact details

HEABENS Medical describes itself on its own site as a wheelchair manufacturer in China dedicated to developing mobility products, stating that it has developed and manufactured lightweight folding wheelchairs since 2015 and citing nine years of manufacturing experience. The same description appears on its LinkedIn company page, which also lists NAICS code 3391, Medical Equipment and Supplies Manufacturing. These are company claims, not independently verified facts. [4][7]

The FDA filing lists a Xuzhou city and postal code 221600 with an address on Liucheng Avenue in Weimiao Town, and names Eric Wang as contact. The manufacturer's site gives a matching street address in Xuzhou, Jiangsu, with the same contact name, an email address and a telephone number. A filing address is a regulatory correspondence address and is not treated here as a verified headquarters. [1][4]

Commercial signals and limits of the record

A LinkedIn post dated 2025-10-20 announces that Model 0026, described as a folding electric wheelchair, is open for order with distributor pricing available on request. The page's listed activity range runs from 2025-04-25 to 2025-08-23, which does not align with that post date; the discrepancy is unresolved in the available material. [7]

Beyond K262241, the available records contain no recalls, no additional clearances and no enforcement actions for this applicant. Absence of such entries in this collection is not evidence of a clean history or of product performance. The website's language options and product listings indicate an export-oriented catalog, but no customer relationships, certifications or distribution agreements are documented in the sources reviewed. [1][3][5]